Kimberly-Clark Corporation’s SEC filings document its consumer products business, Nasdaq-listed common stock and formal reporting as an operating company. Material-event reports furnish quarterly and annual results, financial condition updates and exhibits, including Inline XBRL cover-page data and earnings releases.
Other filings cover proxy and governance disclosures, shareholder voting matters, executive officer departures and interim accounting-officer responsibilities, compensation arrangements, material agreements, registration-statement and proxy/prospectus materials, and capital-structure information. The record also identifies the company’s common stock with $1.25 par value and the exchange registration for KMB on Nasdaq.
Kimberly-Clark (KMB) estimated third-quarter 2026 net sales at $4.134 billion, compared with $4.150 billion a year earlier, and organic sales growth at (1.3)%, versus 2.5%. Estimated operating profit was $516 million, compared with $621 million. Diluted earnings per share from continuing operations were $1.19, versus $1.01, and adjusted earnings per share from continuing operations were $1.70, versus $1.45.
Diluted earnings per share attributable to Kimberly-Clark were $5.37, including a listed $4.33-per-share IFP Transaction Gain; adjusted earnings per share attributable to Kimberly-Clark were $1.70, versus $1.82. These are management’s preliminary estimates, subject to the quarter-end close, and Deloitte & Touche had not audited or reviewed them. Kimberly-Clark reaffirmed its 2026 outlook as consistent with previous expectations; the outlook reflects assumptions subject to change given the macro environment. Final third-quarter results are scheduled for November 5, 2026.
Kimberly-Clark Corporation reported that holders had tendered Kenvue notes for exchange into up to $7,000,000,000 aggregate principal amount of new Kimberly-Clark notes and cash, and that the required consents had been received for all outstanding series. Kenvue executed a supplemental indenture; the amendments eliminate substantially all restrictive covenants, certain events of default other than failure to pay principal, premium, or interest, the SEC reporting covenant, and certain restrictions on mergers and transfers of property or assets. The amendments become operative only upon settlement.
For each $1,000 principal amount validly tendered and not withdrawn by October 9, 2026, and accepted, eligible holders may receive $970 principal amount of new notes, a $30 principal amount early participation premium, and $1.00 cash. Later tenders through expiration qualify for the notes and premium, but not the cash payment. As of October 9, 2026, $1,475,569,000 of the $1,500,000,000 principal amount of 2053 notes had been tendered, or 98.37%. The stated expiration is October 27, 2026, unless extended; it is expected to be extended to on or about the pending acquisition’s closing. The offers are conditioned on completion of that acquisition, expected in the fourth quarter of 2026, and Kimberly-Clark does not anticipate settlement before November 2, 2026.
Kimberly-Clark Corporation (KMB) said President and Chief Operating Officer Russell Torres notified the company on September 29, 2026, that he will depart effective November 2, 2026, to pursue other opportunities.
Kimberly-Clark Corporation (KMB) commenced exchange offers for any and all outstanding Kenvue notes for up to $7.0 billion aggregate principal amount of new Kimberly-Clark notes and cash, in connection with its pending acquisition of Kenvue. For each $1,000 principal amount validly tendered by October 9, 2026, not withdrawn and accepted, eligible holders who beneficially own the notes at expiration may receive $970 in new notes, a $30 early participation premium in notes and $1.00 in cash. Tenders after that date and by expiration may receive $970 in new notes per $1,000 accepted, subject to rounding.
The offers are conditioned on closing the acquisition, expected in the fourth quarter of 2026, plus other conditions; they expire at 5:00 p.m. New York City time on October 27, 2026, unless extended or terminated. Kimberly-Clark is also soliciting consents to remove substantially all restrictive covenants, certain events of default other than payment failures, the SEC reporting covenant, and certain merger and asset-transfer restrictions from each Kenvue indenture. The new notes would be unsecured senior obligations. Kenvue reported $15.124 billion in net sales and $1.470 billion in net income for fiscal 2025.
KIMBERLY CLARK CORP (KMB) reported initial insider holdings for Suzana Blades, SVP and General Counsel. She holds 6,695 shares of Common Stock directly. She also holds several series of restricted share units (RSUs) tied to Common Stock, including 2,071 underlying shares from 05/01/2026 (2‑year) RSUs that vest 50% on each of the first and second anniversaries, and additional RSUs from 2024–2026 grants with dividends reinvested that vest 30% on each of the first two anniversaries and 40% on the third anniversary of the grant date.
Kimberly-Clark reported modest top-line growth but stronger margins from its core business for the quarter ended June 30, 2026. Net sales from continuing operations were $4.19 billion, up 0.6% year over year, while income from continuing operations was $410 million versus $444 million, reflecting a higher effective tax rate. Adjusted operating profit rose to $757 million and adjusted EPS from continuing operations increased 10.4% to $1.80, driven by productivity savings, tariff refunds and currency tailwinds, partly offset by lower net pricing and the exit of certain businesses.
The company completed the sale of a 51% interest in its International Family Care and Professional business on July 1, 2026 for approximately $1.3 billion in cash and retained a 49% equity stake initially valued at about $1.2 billion; this business is reported as discontinued operations, which posted a $60 million loss this quarter due to separation and tax charges. Kimberly-Clark continues to pursue the pending Kenvue acquisition, expected to involve issuing about 280 million shares and paying roughly $6.7 billion in cash.
The 2024 Transformation Initiative, extended through 2028, has generated cumulative pre-tax charges of $913 million toward an anticipated $1.5 billion, with significant productivity savings already identified. Management also notes short-term pressure from a social-media-driven diaper demand disruption in China and estimates roughly $150 million of incremental 2026 input costs tied to Middle East energy volatility.
Kimberly-Clark Chief Growth Officer Patricia Corsi exercised 966.0000 restricted share units into common stock on July 31, 2026. The vesting generated 966.0000 shares of common stock, and 404.0000 of those shares were automatically surrendered to the issuer at $109.3100 per share to satisfy tax withholding obligations. Following the transaction, she held 1288.0000 restricted share units.
Kimberly-Clark Chief R&D Officer Craig Slavtcheff exercised 5,279 restricted share units on July 31, 2026, receiving the same number of common shares, including dividend-equivalent units. To cover related tax withholding obligations, 2,245 shares of common stock were automatically surrendered to the issuer at $109.3100 per share.
Kimberly-Clark reported second quarter 2026 results with net sales of $4.189 billion, up 0.6 percent year over year. Gross margin was 38.3 percent, and adjusted gross margin was 38.8 percent, up 190 basis points versus the prior year. Operating profit was $633 million, while adjusted operating profit rose to $757 million, up 6.2 percent. Diluted EPS from continuing operations were $1.22, but adjusted EPS from continuing operations increased to $1.80, up 10.4 percent. Diluted EPS attributable to Kimberly-Clark were $1.04, with adjusted EPS attributable of $2.12, also up 10.4 percent.
For the first half of 2026, net sales grew 1.6 percent to $8.352 billion, and adjusted operating profit increased 4.9 percent to $1.489 billion. Cash provided by operations reached $1.653 billion versus $1.097 billion a year earlier, while capital spending was $776 million and dividends paid totaled $843 million. Total debt from continuing operations was $6.5 billion as of June 30, 2026. Results reflected the exit of the U.S. private label diaper business, strong productivity savings, and one-time tariff refunds, partially offset by transformation charges and a social media–driven disruption to diaper sales in China. The company highlighted progress on its Powering Care strategy, including the Suzano joint venture Arbex, a new alternative natural fibers pilot plant, and the pending Kenvue acquisition, and expects 2026 adjusted EPS from continuing operations to grow high single digits on a constant-currency basis.
Kimberly-Clark Corporation filed a Form 144 reporting a proposed sale of 6,144 shares of common stock in connection with restricted stock unit vesting. The notice lists four vesting events: 01/31/2025 (2,008 shares), 05/01/2025 (662 shares), 01/31/2026 (2,078 shares) and 05/01/2026 (1,396 shares). The filing names Merrill Lynch as the broker and is dated 06/15/2026.